期刊
CURRENT DRUG TARGETS
卷 21, 期 3, 页码 288-301出版社
BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/1389450120666190906153652
关键词
Chemotherapy-induced peripheral neuropathy; chemotherapeutic agents; chemokines; neuroinflammation; CCL2; CX3CL1; CXCL1
资金
- National Major Scientific and Technological Special Project for Significant New Drugs Development [2018ZX09301043-001, 2016ZX 09101031]
- National Natural Science Foundation of China [81803642]
- Double First-Class Construction Technology Innovation Team Project of China Pharmaceutical University [CPU2018GY23]
- Postgraduate Research & Practice Innovation Program of Jiangsu Province [KYCX18_ 0804]
Background: Some of the current challenges and complications of cancer therapy are chemotherapy-induced peripheral neuropathy (CIPN) and the neuropathic pain that are associated with this condition. Many major chemotherapeutic agents can cause neurotoxicity, significantly modulate the immune system and are always accompanied by various adverse effects. Recent evidence suggests that cross-talk occurs between the nervous system and the immune system during treatment with chemotherapeutic agents; thus, an emerging concept is that neuroinflammation is one of the major mechanisms underlying CIPN, as demonstrated by the upregulation of chemokines. Chemokines were originally identified as regulators of peripheral immune cell trafficking, and chemokines are also expressed on neurons and glial cells in the central nervous system. Objective: In this review, we collected evidence demonstrating that chemokines are potential mediators and contributors to pain signalling in CIPN. The expression of chemokines and their receptors, such as CX3CL1/CX3CR1, CCL2/CCR2, CXCL1/CXCR2, CXCL12/CXCR4 and CCL3/CCR5, is altered in the pathological conditions of CIPN, and chemokine receptor antagonists attenuate neuropathic pain behaviour. Conclusion: By understanding the mechanisms of chemokine-mediated communication, we may reveal chemokine targets that can be used as novel therapeutic strategies for the treatment of CIPN.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据